BNRThin Pro
Commercial- Indications
- Weight management, Body fat reduction
Company intelligence / Profile preview
AceBiome’s flagship probiotic, Lactobacillus gasseri BNR17, is the first MFDS-approved probiotic for body fat reduction and has demonstrated efficacy in three clinical studies for reducing weight, waist/hip circumference, visceral adipose tissue, BMI, and relieving IBS. The company’s products have won multiple industry awards and are commercially available in Korea and internationally. They have also expanded into joint health supplements using plant extracts like ParActin.
2 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AceBiome.